Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Legend Biotech Corporation

Legend Biotech Corporation (LEGN) Stock Overview

Explore Legend Biotech Corporation’s financial performance, market position, analyst ratings, and future outlook.

LEGN●NASDAQ
HealthcareBiotechnology
$22.22
$1.31(5.57%)
U.S. Market opens in 30h 1m

Legend Biotech Corporation (LEGN)

Meyka AI Score

Z

Key Financials

Market Cap4.1B
P/E Ratio-16.46
EPS (TTM)$-0.68
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$13.86
3 Months$23.48
1 Year Target$9.01

LEGN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Legend Biotech Corporation (NASDAQ: LEGN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Legend Biotech Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LEGN on the NASDAQ shows an RSI of 30.96, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $9.01 for the NASDAQ listing.

Key metrics behind Legend Biotech Corporation's NASDAQ-traded stock include a P/E ratio of -16.46 and a market capitalization of 4.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LEGN on the NASDAQ.

Price Performance (NASDAQ: LEGN)

1-Day Change
-5.57%
5-Day Change
-0.80%
1-Month Change
-24.37%
3-Month Change
-7.03%
6-Month Change
16.89%
Year-to-Date (YTD) Change
2.21%
1-Year Change
-49.74%
3-Year Change
-69.57%
5-Year Change
-49.42%
All-Time (Max) Change
-39.95%

Contact Information

https://www.legendbiotech.com
732 317 5050
2101 Cottontail Lane, Somerset, NJ, 08873

Company Facts

31,000 Employees
IPO DateJun 5, 2020
CountryUS
Actively Trading

Frequently Asked Questions